Haleon plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HLNCF research report →
About the company
Haleon plc operates as a global consumer healthcare enterprise, actively involved in the research, development, production, and distribution of a diverse range of products. Its business activities cover extensive regions, including North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers various solutions such as oral hygiene products, pain management remedies, respiratory care items, digestive health aids, and a selection of vitamins, minerals, and supplements.
- CEO
- Brian James McNamara
- IPO
- 2022
- Employees
- 24,561
- HQ
- Weybridge, GB
Price Chart
- Market Cap
- $42.49B
- P/E
- 31.82
- P/S
- 3.90
- P/B
- 2.01
- EV/EBITDA
- 18.99
- Div Yield
- 1.95%
- Gross Margin
- 61.45%
- Op Margin
- 18.85%
- Net Margin
- 12.59%
- ROE
- 6.43%
- ROIC
- 4.13%
- Revenue
- $11.03B · -1.82%
- Net Income
- $1.67B · 15.58%
- EPS
- $0.19 · 18.75%
- Op Income
- $2.58B
- FCF YoY
- 1.60%
- 52W High
- $5.75
- 52W Low
- $4.15
- 50D MA
- $4.54
- 200D MA
- $4.83
- Beta
- 0.25
- Avg Volume
- 26.61K
Get TickerSpark's AI analysis on HLNCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HLNCF coverage
Recent articles, reports, and earnings notes.
No research on HLNCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HLNCF report →Similar companies
Peers in the same neighborhood.